Advanced Biomed Inc. said it will carry out a 1-for-20 reverse stock split of its common shares, effective at the open of Nasdaq trading on Feb. 20, 2026. The company said the move is intended to help regain compliance with Nasdaq’s $1.00 minimum bid price rule, and shares will continue trading under the symbol ADVB with a new CUSIP number, 00752P203.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-020807), on February 26, 2026, and is solely responsible for the information contained therein.
Comments